The different kinds of medication and treatments available for high cholesterol

Written in association with: Dr John Bolodeoku
Published: | Updated: 29/11/2024
Edited by: Karolyn Judge

High cholesterol, particularly elevated low-density lipoprotein (LDL) cholesterol, is a significant risk factor for cardiovascular diseases such as heart attack and stroke. Managing cholesterol levels effectively is crucial, and there are various medications available to reduce cholesterol and maintain heart health, as well as lifestyle modifications. 

 

Different medications and treatments available for high cholesterol.

 

What are the main classes of drugs for high cholesterol?

 

Several medications are designed to target high cholesterol levels, each working in different ways to lower LDL cholesterol, raise high-density lipoprotein (HDL) cholesterol, or reduce triglycerides:

 

1. Niacin (Vitamin B3)
This can raise HDL cholesterol. It also has the ability to lower LDL cholesterol and triglycerides. However, due to potential side effects like flushing and liver toxicity, it is less commonly used today.

 

2. Statins
The medication that is most commonly prescribed to lower LDL cholesterol. They inhibit an enzyme in the liver, and this enzyme is responsible for producing cholesterol. Examples include atorvastatin, simvastatin and rosuvastatin. Statins are highly effective and also help reduce inflammation in the arteries, further lowering cardiovascular risk.

 

3. Fibrates
Fibrates, such as fenofibrate and gemfibrozil, primarily target high triglyceride levels and can modestly increase HDL cholesterol. They are often used alongside other treatments for comprehensive lipid management.


4. Ezetimibe
This medication blocks the absorption of cholesterol in the small intestine, reducing the amount of cholesterol entering the bloodstream. It is often used in combination with statins for enhanced LDL cholesterol reduction.

 

5. Bile acid sequestrants
Drugs like cholestyramine and colesevelam bind to bile acids in the digestive system, which forces the body to use more cholesterol to produce bile acids, thereby lowering blood cholesterol levels.

 

6. PCSK9 inhibitors
These injectable drugs, such as evolocumab and alirocumab, are monoclonal antibodies that improve the liver's ability to remove LDL cholesterol from the blood. PCSK9 inhibitors are particularly beneficial for people who cannot tolerate statins or have familial hypercholesterolemia, a genetic condition causing extremely high cholesterol.
 

7. Lomitapide 

Lomitapide is an oral medication primarily used to manage homozygous familial hypercholesterolaemia (HoFH), a rare and severe inherited condition that causes extremely high cholesterol levels. It works by inhibiting the microsomal triglyceride transfer protein (MTP), which reduces the liver’s production of LDL cholesterol. Lomitapide requires close monitoring due to potential side effects, including gastrointestinal symptoms and liver enzyme abnormalities. Patients on lomitapide must also follow a strict low-fat diet to minimise adverse effects.
 

8. Volanesorsen

Volanesorsen is used to treat certain rare lipid disorders, such as familial chylomicronaemia syndrome (FCS), which can cause dangerously high triglyceride levels. It works by targeting and reducing the production of apolipoprotein C-III, a protein that inhibits the breakdown of triglycerides in the blood. Volanesorsen has been shown to significantly lower triglyceride levels, reducing the risk of complications such as pancreatitis. Common side effects include injection site reactions and flu-like symptoms, and its use is typically reserved for patients with severe or poorly controlled conditions.

 

​9. Inclisiran 
Inclisiran has been shown to significantly lower LDL cholesterol levels and is typically prescribed for patients at high risk of cardiovascular events, such as those with familial hypercholesterolaemia or established cardiovascular disease. It works by reducing the production of PCSK9 in the liver and increases the liver’s ability to remove LDL cholesterol from the bloodstream effectively. It's administered via subcutaneous injection only twice a year after the initial two doses, making it an attractive option for patients who have difficulty adhering to daily medications.

 

10. Omega-3 fatty acids
Prescription omega-3 fatty acid medications, like icosapent ethyl, help reduce triglycerides. These are often recommended for people with very high triglyceride levels.

 

11. Bempedoic acid
This is a newer oral medication that works similarly to statins but has fewer muscle-related side effects, making it an alternative for patients who cannot tolerate statins.

 

12. Evinacumab

Evinacumab is specifically approved for the treatment of homozygous familial hypercholesterolaemia (HoFH). It reducies the activity of ANGPTL3, evinacumab lowers LDL cholesterol and triglycerides, even in patients who don't respond well to other treatments. Administered via intravenous infusion, it has shown impressive results in lowering cholesterol levels. 

 

 

What non-drug treatments are effective?

 

While medications play a key role, lifestyle changes are foundational in managing cholesterol:

  • Diet: Reducing saturated and trans fats, and increasing fibre-rich foods like oats, fruits, and vegetables, can significantly lower LDL cholesterol.
  • Exercise: Regular physical activity raises HDL cholesterol and lowers LDL cholesterol and triglycerides.
  • Weight management: Achieving and maintaining a healthy weight helps improve cholesterol levels.
  • Avoiding smoking and excess alcohol: These lifestyle choices support overall cardiovascular health.

 

 

How is treatment tailored to individual needs?

 

Treatment plans are highly personalised and depend on factors such as baseline cholesterol levels, overall cardiovascular risk, and tolerance to medications. For individuals with high-risk conditions like diabetes or a history of heart attack, aggressive LDL cholesterol reduction using a combination of medications is often recommended.

 

Regular monitoring of cholesterol levels and potential side effects ensures that treatment remains effective and safe over the long term. By combining medication and lifestyle adjustments, most individuals can successfully manage their cholesterol levels and reduce their risk of heart disease.

 

 

Are there any other medications available to reduce high cholesterol?

 

The drugs listed above are the main ones, but there are also other specialised drugs available. 

By Dr John Bolodeoku
Endocrinology, diabetes & metabolism

Dr John Bolodeoku is a leading consultant chemical pathologist based in Basingstoke and London. With more than 25 years of experience in the medical field, Dr Bolodeoku is highly-experienced in chemical pathology. His areas of expertise include the management of cholesterol and diabetes, as well as pre-diabetes, thyroid disease and metabolic syndrome. 
 
Dr Bolodeoku received his MBBS from the University of Ibadan, Nigeria, before going on to receive a Doctor of Philosophy (DPhil) from the University of Oxford in 1996. He began his postgraduate medical career at St Helier Hospital, Carshalton and St Georges Hospital Medical School, London. He has worked in numerous hospitals across the UK since qualifying, and completed his specialist training in chemical pathology (UK-CCST) in 1998. He is also a fellow of the Royal College of Pathologists.
 
Mr Bolodeoku is currently a consultant chemical pathologist at the Candover Clinic at the Basingstoke and North Hampshire Hospital, and at Sterling Healthcare Group, New Malden Diagnostic Centre.  

In addition to his clinical work, Dr Bolodeoku is a leading voice in the pharmaceutical and medical consulting industry. He has served as chief executive officer for The EGCC, a leading global oncology-consulting firm. He has also served as chief medical officer for numerous pharmaceutical companies, including Innoture, Zeab Therapeutic Limited and A1 Labs.
 
Mr Bolodeoku is also a respected medical educator. He has held tutorials and lectures at both the undergraduate and postgraduate levels in esteemed institutions such as the University of London and King’s College London. He has also been involved in the examination of final-year MBBS students at the Royal Free Hospital Medical School. Mr Bolodeoku has published numerous medical articles in peer-reviewed scientific journals, and is a co-author of the textbook Pathology (Pathology Integrated). 

View Profile

Overall assessment of their patients


  • Related procedures
  • Alopecia
    Hyperhidrosis
    Eating disorders
    Erectile dysfunction
    Menopause
    Polycystic ovary syndrome (PCOS)
    Hypertension (high blood pressure)
    Infertility
    Disorder of sexual desire of man
    Clinical nutrition
    This website uses our own and third-party Cookies to compile information with the aim of improving our services, to show you advertising related to your preferences as well analysing your browsing habits. You can change your settings HERE.